We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Menopause symptom
Personalized treatment from board-certified menopause specialists — online, nationwide, starting at $79/mo.
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-07-03
Start nowDeep dive: Read the full Menopause Libido & Intimacy — Desire, Dryness, and What Actually Helps guide →
Decreased sexual desire during perimenopause and menopause has multiple overlapping causes: declining estradiol affects vaginal tissue and arousal, declining testosterone affects desire and motivation, and the cumulative effect of poor sleep, mood symptoms, and body image changes compounds the problem.
Testosterone levels in women decline gradually starting in the 30s. By the time women reach menopause, average testosterone levels are roughly half of what they were in the 20s. For women whose ovaries are surgically removed, testosterone drops by ~50% overnight.
Vaginal dryness and pain with intercourse — known clinically as genitourinary syndrome of menopause (GSM) — make sex physically uncomfortable, which independently lowers desire over time.
Roughly 40% of women report decreased sexual desire during the menopause transition; for many it is one of the most distressing changes.
Kindr providers evaluate the full picture: estradiol levels, testosterone levels, vaginal symptoms, mood, sleep, and relationship factors.
Treatment may include systemic estradiol, vaginal estrogen for GSM, and — for appropriate candidates — physiologic-dose testosterone therapy. Testosterone for women is endorsed by the International Society for the Study of Women's Sexual Health for hypoactive sexual desire disorder in postmenopausal women.
For women who cannot use hormones, Kindr providers can prescribe ospemifene for GSM and other options for sexual function.
Expected timeline: Vaginal symptoms typically improve within 2 to 4 weeks of starting vaginal estrogen. Desire improvements with testosterone usually take 8 to 12 weeks.
Loss of desire during menopause is one of the most common and least openly discussed symptoms. It is not a sign that you no longer love your partner. It is not a moral failing.
Most physicians never bring it up. Most women never mention it. Kindr treats it as the medical condition it is.
Women with low libido often also experience:
vaginal dryness during menopause
Mood Changesmood changes during menopause
Fatiguefatigue during menopause
Medically reviewed by Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team (physician-supervised)
NPI 1609792902 · Last reviewed: July 3, 2026
Yes, when clinically appropriate. Testosterone for women is dosed at roughly one-tenth of male doses and is monitored with periodic lab work.
At physiologic doses with appropriate monitoring, testosterone is well-tolerated. Higher doses can cause acne, facial hair, and voice changes — which is why Kindr uses careful, conservative dosing.
For some women, yes. For others, adding testosterone or treating vaginal symptoms is needed for full effect.
No — though psychological factors matter. The hormonal contributions are real, measurable, and treatable.
Yes. Kindr providers prescribe libido-related menopause treatment via telehealth in all 50 states.
Personalized care from board-certified menopause providers, delivered to your door.
Start nowKindr's primary service for treating low libido and related menopause symptoms.